Kaushik Datta

Mergers and acquisitions (M&A) bring exciting growth opportunities for biotechs, startups, and small pharma companies, but integrating supply chains can be a complex and high-stakes challenge. This panel workshop will explore real-world strategies for streamlining supply chain integration during M&A, minimizing disruptions, and ensuring operational continuity.

·        Discuss supply chain challenges and opportunities in biotech and small pharma M&A

·        Learn strategies for integrating systems, processes, and logistics while maintaining business continuity

·        Share best practices for ensuring transparency, agility, and risk mitigation during transitions

Start your day with a high-impact, interactive session designed to spark insight, collaboration, and forward thinking. This isn’t just a warm-up — it’s a deep dive into what’s working, what’s not, and where the industry is headed.

Through dynamic breakout discussions led by our esteemed supply chain thought leaders and our Advisory Board, you’ll:

·        Share best practices

·        Explore current benchmarks

·        Co-create actionable solutions

Each breakout will focus on timely, carefully curated topics essential to the future of pharma supply chain strategy. Get ready to exchange ideas, challenge assumptions, and walk away with tangible takeaways to elevate your roadmap:

 1.      Acceleration: Priya Durvasula, PhD, VP, Global Supply Chain, Quality Digital & Tech, GSK

2.      Sustainability: Luiz Barberini, Operations Manager - External Manufacturing LatAm, Bayer

3.      AI Cold Chain Initiatives: Lee Feltman, Global Logistics Team -Cold Chain Consultant, Elanco

4.      Mergers & Acquisitions and Quality Management Systems – Gisele Fahmi, Director, Digital Integration Quality Management Systems, Pfizer

5.      Security: Charles Forsaith, VP, HDA - Healthcare Distribution Alliance

6.      Digital Transformation: Kaushik Datta, former VP, North America Contract Manufacturing Operations, Haleon